Back

Discussion - Managing diabetes & CVD: is epigenetics a new way forward?

26 August 2017 (16:25 - 16:30)
Organised by:
Congress Presentation Part of: Managing diabetes & cardiovascular disease (CVD): is epigenetics a new way forward? (EBAC Accredited) Drug therapy ESC Premium Access ESC Congress 2017

About the speaker

Photo
Professor Ray Kausik

4 More presentations in this session

Presentation thumbnail
Introduction - Managing diabetes & CVD: is epigenetics a new way forward?
Professor L. Badimon (Barcelona, ES)
Presentation thumbnail
Managing high risk diabetes patient with cardiovascular disease: what works, and what else can we do?
Professor R. Kausik
Presentation thumbnail
Promise of epigenetic modulation as a target in atherosclerotic patients.
Professor E. Stroes (Amsterdam, NL)
Presentation thumbnail
Insights from the first trials in epigenetics in human: what is the way forward?
Professor S. Nicholls (Melbourne, AU)

Access the full session

Session thumbnail
Managing diabetes & cardiovascular disease (CVD): is epigenetics a new way forward? (EBAC Accredited)

The Event

Event poster

ESC Congress 2017

26 August 2017 16:25 CET
You may be interested in
thumbnail
Congress Session
Guidelines in Practice: 2023 ESC Guidelines for the Management of Cardiovascular Disease in Patients with Diabetes
27 August 2023
thumbnail
Congress Session
Heart failure in the era of precision medicine: insights into pathophysiology and emerging treatments
17 May 2025
thumbnail
Congress Presentation
Longevity: the next health-wealth challenge
1 September 2025
thumbnail
Congress Session
Obesity as a cardiovascular disease: integrated management
3 April 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources